C.E. Credits

The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


FEB 13 - 14 2019

Laboratory Animal Sciences 2019

Our 8th Annual Laboratory Animal Sciences Virtual Event is now available On-Demand!  The event will remain open 6 months from the date of the live event.  The webinars will be available for unlimited on-demand viewing.


Topic's for this years event included: 

  • Digitization, Digitalization & Digital Transformation:
    • Digital transformation has affected the clinical phase of the drug development journey by improving efficiencies, patient engagement and allowing for utilization of computational and other technologies. This track will address topics such as data collection, flow, storage and analytics and digital transformation case studies in clinical phase and the potential for digital transformation in preclinical phase.  Preclinical in vivo phase is in initial stages of engaging with digitization and digitalization, which presents opportunities for learning from clinical colleagues how to implement these technologies.
  • Non-Traditional In Vivo & In Vitro Models:
    • This track will address the clinical relevance and translational challenges in drug development with in vivo large animal models (dogs, pigs, cats) and in vitro organ on the chip models as potential solutions. Sessions will address the possibilities and challenges of performing preclinical trials with dogs and cats, discuss the need for more clinically relevant preclinical in vivo and in vitro models, and current reality and capabilities of organ on the chip technologies.
       

Laboratory Animal Sciences 2019 brought together scientists from basics sciences to bioinformatics, clinicians  veterinary technicians, veterinarians, technical support staff and compliance personnel from around the world to learn about recent advances and challenges within preclinical phases of drug development.

RACE Continuing Educational Credits

 

The 2019 conference has been approved by the American Association of Veterinary State Boards for Continuing Education for veterinarians and veterinary technicians to offer RACE CE credits, and will also meet AALAS and CALAS continuing education criteria.  By attending this event, you can earn 1 RACE CE credit per presentation for a maximum of 15 credits.

Use #LRlas to follow the conversation


Speakers
  • Head of Emerging Technologies, LAS, Novartis
  • Director, Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health
  • Professor, Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University
  • CEO & Founder, RockStep Solutions
  • GSK Associate Fellow, Comparative & Translational Sciences Veterinarian, GlaxoSmithKline
  • Principal Solution Specialist, Data & AI, Microsoft
  • Vice President/Principal, RockStep Solutions
  • Technical Associate Director, Novartis Institutes for BioMedical Research
  • Senior Investigator and Group Leader, Respiratory Biology, Novartis Institutes for BioMedical Research
  • Professor, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University
  • Chief Scientific Officer, Vium
  • Founder & Chief Operating Officer, Naason Science, Inc.
  • Associate Director for Special Initiatives Office of the Director National Center for Advancing Translational Sciences, National Institutes of Health
  • Associate Director of Mechanistic and Investigative Toxicology, Takeda Pharmaceuticals
  • Engagement Manager, Ernst and Young
  • Scientific Director, Analytical Development, Small Molecule Pharmaceutical Development, The Janssen Pharmaceutical Companies of Johnson & Johnson

Show Resources
You May Also Like
NOV 14, 2019 06:00 AM PST
C.E. CREDITS
NOV 14, 2019 06:00 AM PST
Ten years ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2019 Clinical Diagnostics and Research Virtual Event will again bring together clinicians,...
JUN 20, 2019 06:00 AM PDT
C.E. CREDITS
JUN 20, 2019 06:00 AM PDT
LabRoots and the Precision Medicine Planning Committee are pleased to announce the 4th Annual Precision Medicine Virtual Event. Precision Medicine 2019, a two-day event held June 19-20, will...
AUG 22, 2019 06:00 AM PDT
C.E. CREDITS
AUG 22, 2019 06:00 AM PDT
LabRoots is pleased to announce a new addition to our virtual conference line up for 2019, Forensics & Toxicology! The exciting field of Forensics/Toxicology is focused on a blend of biology...
SEP 26, 2019 06:00 AM PDT
C.E. CREDITS
SEP 26, 2019 06:00 AM PDT
LabRoots and the Cell Biology Planning Committee are please to announce the 3rd Annual Cell Biology Virtual Event, providing an opportunity to discuss recent discoveries in biological researc...
NOV 12, 2020 06:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 12, 2020 06:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Ten years ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2020 Clinical Diagnostics and Research Virtual Event will again bring together clinicians,...
MAR 25, 2020 06:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
MAR 25, 2020 06:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
 LabRoots is pleased to announce the 3rd Annual Cannabis Sciences Virtual Event. LabRoots will host the event March 25, 2020. The Cannabis Sciences planning comm...
Agenda
  • FEB 13, 2019 06:00 AM PST
    Speaker: Claudio Mirti
    SEE ABSTRACT | Continuing Education: RACE
  • FEB 13, 2019 07:30 AM PST
    Speaker: Szczepan Baran, VMD, MS
    SEE ABSTRACT | Continuing Education: RACE
  • FEB 13, 2019 09:00 AM PST
    SEE ABSTRACT | Continuing Education: RACE
    Chuck Donnelly
    CEO & Founder, RockStep Solutions
    Julie Morrison
    Vice President/Principal, RockStep Solutions
  • FEB 13, 2019 10:30 AM PST
    Speaker: Weihsueh Chiu, PhD
    SEE ABSTRACT | Continuing Education: RACE
  • FEB 13, 2019 10:30 AM PST
    Speaker: Sean Maguire, VMD, MS, DACLAM
    SEE ABSTRACT | Continuing Education: RACE
  • FEB 13, 2019 12:00 PM PST
    Speaker: Patrick Sweeney, PhD
    SEE ABSTRACT | Continuing Education: RACE
  • FEB 13, 2019 01:30 PM PST
    Speaker: Laura Schaevitz, PhD
    SEE ABSTRACT | Continuing Education: RACE
  • FEB 14, 2019 06:00 AM PST
    Speaker: Wu Wu
    SEE ABSTRACT | Continuing Education: RACE
  • FEB 14, 2019 06:00 AM PST
    Speaker: Danilo Tagle, PhD, M.S.
    SEE ABSTRACT | Continuing Education: RACE
  • FEB 14, 2019 07:30 AM PST
    Speaker: Amy LeBlanc, DVM DACVIM
    SEE ABSTRACT | Continuing Education: RACE
  • FEB 14, 2019 09:00 AM PST
    Speaker: Yohann Potier, PhD
    SEE ABSTRACT | Continuing Education: RACE
  • FEB 14, 2019 09:00 AM PST
    Speaker: Ivan Rusyn, PhD
    SEE ABSTRACT | Continuing Education: RACE
  • FEB 14, 2019 10:30 AM PST
    Speaker: Matthew Wagoner, PhD
    SEE ABSTRACT | Continuing Education: RACE
  • FEB 14, 2019 12:00 PM PST
    Speaker: David Rowlands, PhD
    SEE ABSTRACT | Continuing Education: RACE
  • FEB 14, 2019 01:30 PM PST
    Speaker: Gorm Yoder, PhD
    SEE ABSTRACT | Continuing Education: RACE
  • Digitization, Digitalization & Digital Transformation
  • FEB 13, 2019 06:00 AM PST
    Speaker: Claudio Mirti
    SEE ABSTRACT | Continuing Education: RACE
  • FEB 13, 2019 09:00 AM PST
    SEE ABSTRACT | Continuing Education: RACE
    Chuck Donnelly
    CEO & Founder, RockStep Solutions
    Julie Morrison
    Vice President/Principal, RockStep Solutions
  • FEB 13, 2019 10:30 AM PST
    Speaker: Sean Maguire, VMD, MS, DACLAM
    SEE ABSTRACT | Continuing Education: RACE
  • FEB 13, 2019 12:00 PM PST
    Speaker: Patrick Sweeney, PhD
    SEE ABSTRACT | Continuing Education: RACE
  • FEB 13, 2019 01:30 PM PST
    Speaker: Laura Schaevitz, PhD
    SEE ABSTRACT | Continuing Education: RACE
  • FEB 14, 2019 06:00 AM PST
    Speaker: Wu Wu
    SEE ABSTRACT | Continuing Education: RACE
  • FEB 14, 2019 09:00 AM PST
    Speaker: Yohann Potier, PhD
    SEE ABSTRACT | Continuing Education: RACE
  • Non-Traditional In Vivo & In Vitro Models
  • FEB 13, 2019 07:30 AM PST
    Speaker: Szczepan Baran, VMD, MS
    SEE ABSTRACT | Continuing Education: RACE
  • FEB 13, 2019 10:30 AM PST
    Speaker: Weihsueh Chiu, PhD
    SEE ABSTRACT | Continuing Education: RACE
  • FEB 14, 2019 06:00 AM PST
    Speaker: Danilo Tagle, PhD, M.S.
    SEE ABSTRACT | Continuing Education: RACE
  • FEB 14, 2019 07:30 AM PST
    Speaker: Amy LeBlanc, DVM DACVIM
    SEE ABSTRACT | Continuing Education: RACE
  • FEB 14, 2019 09:00 AM PST
    Speaker: Ivan Rusyn, PhD
    SEE ABSTRACT | Continuing Education: RACE
  • FEB 14, 2019 10:30 AM PST
    Speaker: Matthew Wagoner, PhD
    SEE ABSTRACT | Continuing Education: RACE
  • FEB 14, 2019 12:00 PM PST
    Speaker: David Rowlands, PhD
    SEE ABSTRACT | Continuing Education: RACE
  • FEB 14, 2019 01:30 PM PST
    Speaker: Gorm Yoder, PhD
    SEE ABSTRACT | Continuing Education: RACE
Speakers

  • Szczepan Baran, VMD, MS
    Head of Emerging Technologies, LAS, Novartis
    Biography
      Szczepan Baran, VMD, MS is the Head of Emerging Technologies at Novartis Institutes for Biomedical Research. In this position, he leads global strategic initiatives focused on digital efforts to uncover new scientific insights, generate scientific breakthroughs and collect more physiologically and clinically relevant data & endpoints to optimize reproducibility and clinical translation. He has held multiple faculty and startup positions and has served on multiple boards. Currently he is serving as Board Member of North America 3Rs Collaborative and is a Chair of the 3Rs Working Group International Consortium for Innovation & Quality in Pharmaceutical Development. Witin the IQ he leads Digital Vivarium Scoping and Animal Studies Modernization Working Groups. Dr. Baran is a graduate of the University of Delaware and the University Of Pennsylvania School of Veterinary Medicine. He completed a residency in Laboratory Animal Medicine and a Masters of Science in Comparative Medicine at the University Of Washington School Of Medicine.
    • Amy LeBlanc, DVM DACVIM
      Director, Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health
      Biography
        Amy LeBlanc is board-certified veterinary oncologist and the Director of the intramural National Cancer Institute's Comparative Oncology Program. In this position she conducts preclinical mouse and translational canine studies that are designed to inform the drug and imaging agent development path for human cancer patients. She also advises leading pharmaceutical companies as well as NCI's Division of Cancer Treatment and Diagnosis on the inclusion of pet dogs with cancer into the development path of novel approaches for a variety of malignancies, including immunotherapeutics, targeted small molecules, oncolytic viruses, and cancer imaging agents. She directly oversees the NCI Comparative Oncology Trials Consortium (COTC), which provides infrastructure necessary to connect participating veterinary academic institutions with stakeholders in drug development to execute fit-for-purpose comparative clinical trials in novel therapeutics and imaging agents. Dr. LeBlanc obtained her veterinary degree from Michigan State University, and completed post-graduate training in small animal medicine, surgery and oncology at Texas A&M University and Louisiana State University. Prior to her appointment at NIH, Dr. LeBlanc was an Associate Professor with tenure and Director of Translational Research at the University of Tennessee College of Veterinary Medicine (CVM) and UT Graduate School of Medicine (GSM). Dr. LeBlanc's group at the University of Tennessee published the first comprehensive studies describing molecular imaging of dogs and cats using PET/CT, focusing on the forward and back-translation of 18F-labelled radiopharmaceuticals.
      • Weihsueh Chiu, PhD
        Professor, Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University
        Biography
          Weihsueh A. Chiu, Ph.D. is a professor in the Department of Veterinary Integrative Biosciences in the College of Veterinary Medicine and Biomedical Sciences at Texas A&M University. Before joining the university, he worked at the U.S. Environmental Protection Agency (EPA) for more than 14 years, most recently as chief of the Toxicity Pathways Branch in the Integrated Risk Information System (IRIS) Division of the National Center for Environmental Assessment. Throughout his career, he has been involved in a diverse span of risk-related topics, such as defense against chemical-biological warfare agents, radioactive contamination in biosolids, human health risks from environmental chemical exposures, and the interface between science and policy. His recent research has focused on human health risk assessment, particularly with respect to toxicokinetics, mechanisms of toxicity, physiologically-based pharmacokinetic modeling, dose-response assessment, characterizing uncertainty and variability, systematic review, and meta-analysis. He has a particular interest in the development and use of Bayesian and probabilistic methods. Dr. Chiu has served on a variety of expert advisory committees for U.S. federal, state, and Canadian government agencies; the U.S. National Academies of Sciences, Engineering, and Medicine; the World Health Organization; and the Organisation for Economic Cooperation and Development. Dr. Chiu received an AB in Physics from Harvard University, a MA and PhD in Physics from Princeton University, and a Certificate in Science, Technology, and Environmental Policy from the Woodrow Wilson School of Public and International Affairs.
        • Chuck Donnelly
          CEO & Founder, RockStep Solutions
          Biography
            Chuck Donnelly is CEO and co-founder of RockStep Solutions, a company focused on SaaS informatics solutions for biomedical research. Prior to RockStep, Chuck was the Director of Computational Sciences of the Jackson Laboratory (JAX), a genetics research institute focused on the study of the biology and genetics of human diseases. For the past 25 years, Chuck has led innovative technology development teams both at JAX and UC Berkeley (UCB) with funding from the NIH, HHMI, and NASA. At UC Berkeley, Chuck developed novel signal detection algorithms and real-time flight software for astrophysics telescopes operating on space orbiting platforms. He is currently the principal investigator on a recently awarded innovation grant from the NIH to develop a next generation platform for animal lab informatics. He has lectured around the world and published articles on algorithms and research information systems. RockStep Solutions recently released an informatics platform for drug discovery called Climb™. Climb is a SaaS collaboration suite for managing preclinical research operations and data. RockStep is revolutionizing research laboratory workflows with state-of-the-art Azure-cloud technologies such as IoT and Machine Learning.
          • Sean Maguire, VMD, MS, DACLAM
            GSK Associate Fellow, Comparative & Translational Sciences Veterinarian, GlaxoSmithKline
            Biography
              Sean Maguire, VMD, MS, DACLAM is a Comparative and Translational Sciences Veterinarian at GSK. He received his Veterinary degree from the University of Pennsylvania and his Master's degree in chemistry from Lehigh University. He is Diplomate of the American College of Laboratory Animal Medicine and has extensive experience in the pharmaceutical industry working across a range of species and disease areas and a special interest in animal model development.
            • Claudio Mirti
              Principal Solution Specialist, Data & AI, Microsoft
              Biography
                Claudio Mirti is passionate about the potential of AI to empower us all to accomplish more, drive better business outcomes and achieve breakthroughs that redefine what's possible. From changing the transportation landscape or discovering new ways of protecting the planet to reinventing healthcare to connecting with customers. The opportunities are endless. As a Business Developer, Claudio Mirti has a customer-focused strategic approach to leverage digital technologies to design and build innovative game-changing solutions. He works for an American multinational technology company. Furthermore, he is the founder of different courses in higher education in Switzerland and the New York University for Professional Studies with focus on Design Thinking, AI and Chatbots. Claudio Mirti has a commercial background (Sales and Marketing) and holds a Master degree in Information Systems Management from the University of Applied Sciences and Arts Northwestern Switzerland. Additionally, he holds a certification in advertising and innovation from the Boston University and a certification in digital ecosystems for startups from the New York University. As an advisory board member, he coaches startups and published different articles on business development and ideation. He commutes between Zürich and New York City.
              • Julie Morrison
                Vice President/Principal, RockStep Solutions
                Biography
                  Julie Morrison is Vice President and a Principal of RockStep Solutions, a SaaS informatics company with solutions for data and operations management in drug discovery research. Julie manages RockStep's product and sales teams and works closely with the CEO and Scientific Advisory Board in developing company strategy. Julie began her technical career at The Jet Propulsion Laboratory in Pasadena, California, where she worked on developing a biosensor to detect Bacillus spores in space. She also worked at IDEXX Laboratories, where she developed novel assays for testing public drinking water supplies. Prior to joining RockStep, Julie founded several science based small businesses. Julie has lectured on information management in animal model research and published thought-leadership articles on data and operations management systems for the lab of the future. Julie has a degree in Microbiology from the University of Maine.
                • Yohann Potier, PhD
                  Technical Associate Director, Novartis Institutes for BioMedical Research
                  Biography
                    Yohann is a Technical Associate Director at the Novartis Institute for Biomedical Research. He studied biotechnology and informatics in France followed by a Ph.D. in computational chemistry at the University of Zurich. Yohann joined PerkinElmer Informatics (formerly CambridgeSoft) as a business analyst where he worked with various life sciences customers to deliver informatics solutions. He has been working for the past 3 years at Novartis in the Scientific Information Systems team. During this time, Yohann worked with scientists and engineers from Novartis providing Informatics tools to perform cutting edge biology research in a collaborative open science environment.
                  • David Rowlands, PhD
                    Senior Investigator and Group Leader, Respiratory Biology, Novartis Institutes for BioMedical Research
                    Biography
                      David J. Rowlands, Ph.D is a Senior Investigator and group leader within the Respiratory Diseases Area at the Novartis Institutes for Biomedical Research (NIBR). Before joining NIBR, David was a postdoctoral research at Columbia University, New York City focused on elucidating novel mechanisms responsible for regulating severity of lung inflammation following injury. Throughout his career, David has utilized a multi-disciplinary approach to address scientific questions with a strong focus on utility of in vivo pharmacology and translational ex vivo and in vitro model systems to replicate physiological process. Over the last 8 years at NIBR, David and his team have enabled and supported multiple drug discovery programs spanning diseases including COPD, cystic fibrosis, pulmonary arterial hypertension and idiopathic pulmonary fibrosis at all stages of the drug discovery pipeline from target validation through to support of a PhII clinical trial. Although in vivo pharmacology remains a key focus of David's group, over the last few years, his team have increasingly incorporated alternative systems to address complex scientific questions including use of ex vivo tissue preparations such as the isolated perfused lung or ex vivo tracheal tissue to a more recent consideration of microfluidic 'organ on a chip' technology.
                    • Ivan Rusyn, PhD
                      Professor, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University
                      Biography
                        Ivan Rusyn is Professor in the Department of Veterinary Integrative Biosciences in the College of Veterinary Medicine & Biomedical Sciences at Texas A&M University in College Station, TX. Prior to joining Texas A&M University, he was Professor of Environmental Sciences and Engineering at the University of North Carolina at Chapel Hill where he also served as an associate director of the Curriculum in Toxicology and deputy director of the Superfund Research Program. His laboratory has an active research portfolio with a focus on the mechanisms of chemical toxicity, the genetic determinants of susceptibility to toxicant-induced disease, and computational toxicology. He has served on many US national scientific committees and is currently a member of the National Research Council Committee on Toxicology. In addition, he is serving on the Board of the Scientific Councilors of the National Institute of Environmental Health Sciences and the Science Advisory Board for the NC Department of Environmental Quality. Dr. Rusyn served on seven World Health Organization/International Agency for Research on Cancer monograph working groups (as an overall chair, or a chair of "Mechanistic and Other Relevant Evidence" sub-group) and an expert for WHO-JMPR. His other service commitments include membership on the Research Committee of the Health Effects Institute in the United States. Dr. Rusyn received a doctor of medicine degree from Ukrainian State Medical University in Kiev and a Ph.D. in toxicology from UNC-Chapel Hill. He conducted postdoctoral research at the Massachusetts Institute of Technology and Heinrich-Heine University in Dusseldorf, where he was a DAAD fellow. Dr. Rusyn's laboratory has been funded by the grants and cooperative research agreements from the National Institutes of Health and US Environmental Protection Agency, and contracts with the American Chemistry Council and the European Petroleum Refiners Association (Concawe division).
                      • Laura Schaevitz, PhD
                        Chief Scientific Officer, Vium
                        Biography
                          Laura Schaevitz has more than 20 years of experience with In vivo animal studies. As Chief Scientific Officer at Vium, she oversees the development of animal models and draws upon her experiences as a molecular and behavioral neuroscientist to direct the application of Vium's digital metrics to the animal models. In past experiences, Laura utilized a broad spectrum of mouse models including transgenic and nutrition-induced models of neurodevelopmental disorders such as autism, schizophrenia, Rett syndrome, and blindsight. Laura received her PhD in Neuroscience at Stanford University in 2006.
                        • Patrick Sweeney, PhD
                          Founder & Chief Operating Officer, Naason Science, Inc.
                          Biography
                            Patrick is co-counder and COO of Naason Science Inc. He has served as CEO, Managing Director of Neurology and Director of Business Development at Charles River Finland. Prior to that he founded a CNS focussed CRO which got acquired by Charles River. He has unparalleled experience in the discovery and development of new drugs, with a particular focus on the CNS.
                          • Danilo Tagle, PhD, M.S.
                            Associate Director for Special Initiatives Office of the Director National Center for Advancing Translational Sciences, National Institutes of Health
                            Biography
                              Dan Tagle is associate director for special initiatives at NCATS. He also recently served as acting director of the NCATS Office of Grants Management and Scientific Review and currently serves as executive secretary to the NCATS Advisory Council and Cures Acceleration Network Review Board. Prior to joining NCATS, Tagle was a program director for neurogenetics at the National Institute of Neurological Disorders and Stroke (NINDS), where he was involved in developing programs concerning genomics-based approaches for basic and translational research in inherited brain disorders. Prior to joining NINDS in 2001, Tagle was an investigator and section head of molecular neurogenetics at the National Human Genome Research Institute and has been involved in the highly collaborative effort toward the positional cloning of genes for Huntington's disease, ataxia-telangiectasia and Niemann-Pick disease type C. He has served on numerous committees and advisory boards, including the editorial boards of the journals Gene and the International Journal of Biotechnology. Tagle obtained his Ph.D. in molecular biology and genetics from Wayne State University School of Medicine in 1990. He was an NIH National Research Service Award postdoctoral fellow in human genetics in the laboratory of Francis S. Collins, M.D., Ph.D., at the University of Michigan. Tagle has authored more than 150 scientific publications and has garnered numerous awards and patents.
                            • Matthew Wagoner, PhD
                              Associate Director of Mechanistic and Investigative Toxicology, Takeda Pharmaceuticals
                              Biography
                                Matt Wagoner leads the Global Investigatory Toxicology network for Takeda Pharmaceuticals, where their team applys microphysiological systems (MPS) as predictive and mechanistic toxicology tools in support of discovery-phase projects. Before Takeda, Matt led the mRNA safety strategy for AstraZeneca Pharmaceuticals, and worked to develop and deploy MPS tools in support of projects. Matt has his PhD in Molecular and Cellular Pharmacology from the University of Wisconsin-Madison and bachelors in biochemistry from the University of Illinois Urbana Champaign.
                              • Wu Wu
                                Engagement Manager, Ernst and Young
                                Biography
                                  Wu is an Engagement Manager in Ernst & Young's Advisory Practice focused on life science strategy. He has 10+ years of life sciences industry experience, starting in clinical trials, focusing on carboplatin research across HER2 epithelial growth factor receptor, following with patient services in the southern California market, and now supporting large scale process transformations, strategy, digital enablement and E2E process design in the clinical phase 3 and early commercialization space (first 18 months). He holds a BS in Biochemistry, focus on oncology research, a Master of Public Policy in healthcare/access, and a MBA focused on Strategy, Digital Enablement and Operations.
                                • Gorm Yoder, PhD
                                  Scientific Director, Analytical Development, Small Molecule Pharmaceutical Development, The Janssen Pharmaceutical Companies of Johnson & Johnson
                                  Biography
                                    Dr. Yoder received his PhD in analytical chemistry from the University of Illinois at Chicago. He has over 15 years of industrial experience in analytical development and characterization supporting API and formulation development. He has solid experience in oral (solid and liquid), parenteral, inhalation dosage forms (MDI, DPI, and nebulized products), and large molecule therapeutics. He also has broad experience in characterization of small molecules and bio-macromolecules and he has exploited several analytical tools to support API and formulation development initiatives.
                                  Sponsored By

                                  For information on becoming a sponsor or exhibitor, please click here.


                                  Posters

                                  POSTER SUBMISSION GUIDELINES

                                  Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer-reviewed. Submission is free.


                                  SUBMIT YOUR ABSTRACT

                                  Enter the following information to this Submission Form:

                                  • Poster Title
                                  • Your Name
                                  • Your Institution
                                  • Your Email
                                  • Abstract describing the poster


                                  All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

                                  If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

                                  Questions? Email Posters@LabRoots.com

                                  LabRoots Policy

                                  Committee

                                  To download the Program Committee brochure here.


                                  • Szczepan Baran

                                    Szczepan Baran, VMD, MS is the Head of Emerging Technologies at Novartis Institutes for Biomedical Research. In this position, he leads global strategic initiatives focused on digital efforts to uncover new scientific insights, generate scientific breakthroughs and collect more ...

                                    See more See less
                                  • Nicole Duffee, DVM, PhD

                                    Dr. Nicole Duffee is the Director of Education & Scientific Affairs for the American Association for Laboratory Animal Science. She leads the AALAS Learning Library development team for the online learning platform and courses in laboratory animal science. She oversees and ...

                                    See more See less
                                  • Marcel Perret-Gentil

                                    Dr. Perret-Gentil serves as University Veterinarian and Director of the Laboratory Animal Resources Center (LARC) at the University of Texas at San Antonio (UTSA) as well as Attending Veterinarian for the South Texas Accelerated Research Therapeutics. His experience involves a ...

                                    See more See less
                                  • Letty Medina, DVM, DACLAM

                                    Letty Medina earned her BS in Biology at the University of Notre Dame and her DVM degree from Texas A&M University. She completed her Laboratory Animal Medicine post-doctoral training at the University of Illinois, Chicago. She is a Diplomate of the American College of Laboratory ...

                                    See more See less
                                  • Klas Abelson, PhD

                                    Dr. Klas Abelson obtained a degree of Master of Medical Sciences in 2001 and a PhD in Comparative Medicine and Lab Animal Science in 2005, from Uppsala University, Sweden. The area of his research was originally focused on the development of experimental models for studying pain ...

                                    See more See less
                                  • Jennifer Wilk, DVM, DACLAM

                                  • Jeffrey Everitt, DVM

                                    Jeff Everitt received his DVM from Cornell University and then completed a residency in comparative pathology at the University of Pennsylvania and a postdoctoral research appointment at the University of Illinois. Dr. Everitt served for 17 years on the senior scientific staff of ...

                                    See more See less
                                  • Javier Guillen, DVM

                                    He obtained his veterinary medicine degree at the University of Zaragoza (Spain) in 1990, and was for 17 years Director of the Laboratory Animal Services at the University of Navarra in Pamplona, Spain. In parallel, between 2003 and 2008 he was also a member of the Association ...

                                    See more See less
                                  • Debra Hickman, DVM, MS, DACLAM

                                    Debra Hickman, DVM, MS, DACLAM, is the Director of the Laboratory Animal Resource Center at Indiana University Medical School in Indianapolis, IN. She obtained her veterinary degree and completed residency training in laboratory animal medicine at the University of Illinois at ...

                                    See more See less
                                  • Christian Lawrence, MS

                                    Christian Lawrence is currently the Manager of the Aquatic Resources Program (ARP) at Boston Children's Hospital (BCH). ARP administers the zebrafish program at BCH, which is one of the largest and most active of its kind in the world. Mr. Lawrence also serves as a faculty ...

                                    See more See less
                                  • Andrea Gay, BS

                                    Andrea Gay is Regional Sales Manager for the Southern Territory of the U.S. as well as the International Sales Representative for The Andersons Bedding Products. Andrea graduated from MacMurray College in Jacksonville, IL with a bachelor's degree in elementary education and ...

                                    See more See less
                                  • Stacy Pritt, DVM, MS, MBA, CPIA, DACAW

                                    Dr. Stacy Pritt is the Director of the Institutional Animal Care and Use Committee (IACUC) Office at the University of Texas (UT) Southwestern Medical Center in Dallas, TX. In this capacity, she oversees regulatory compliance for one of the largest animal research programs in ...

                                    See more See less
                                  Help

                                  General LabRoots Questions

                                  For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                                  Contact us

                                  Virtual Events and Webinars

                                  Supported Configurations

                                  • Operating System Internet Explorer Firefox Chrome Safari
                                    Vista IE8+ FF10+ Chrome15+
                                    Windows 7 IE8+ FF10+ Chrome15+
                                    Windows 8 IE10 FF10+ Chrome15+
                                    Mac OS X   FF10+ Chrome15+ Safari5.1+
                                  • Cookie settings: session cookies enabled
                                  • Browser configuration must have JavaScript enabled
                                  • Adobe Flash player 10.2 or later

                                  To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                  Internet Connection

                                  • A minimum of 100Kbps is recommended for audio-only events
                                  • A minimum of 300Kbps is recommended for speaker on-video events

                                  Computer Equipment

                                  • Screen Resolution: Minimum 1024x768
                                  • Video Card: 65,000 colors minimum
                                  • Sound card and speakers (or headphones) for hearing webcast in full format
                                  • Audio Card: 16-bit minimum
                                  • RAM: 512MB of free RAM

                                  Firewall Protocol

                                  • HTTP on port 80 or HTTPS on port 443
                                  • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                  • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                  Work-At-Home Attendees

                                  • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                  For A Seamless Experience

                                  When using a mobile device, FREE Mobile Apps are available:

                                  - For viewing Webinars:

                                  - For viewing Virtual Events

                                  Attendee Guide

                                  • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                  Virtual Event and Webinar Support:

                                  Continuing Education (CME/CE) Support

                                  Loading Comments...
                                  Show Resources